关注
Anik Patel
标题
引用次数
引用次数
年份
Impact of pharmacist administration of influenza vaccines on uptake in Canada
SA Buchan, LC Rosella, M Finkelstein, D Juurlink, J Isenor, F Marra, ...
Cmaj 189 (4), E146-E152, 2017
1032017
Mobile health for early retention in HIV care: a qualitative study in Kenya (WelTel Retain)
K Smillie, NV Borek, ML Kop, A Lukhwaro, N Li, S Karanja, AR Patel, ...
African Journal of Aids Research 13 (4), 331-338, 2014
712014
Effect of an interactive text-messaging service on patient retention during the first year of HIV care in Kenya (WelTel Retain): an open-label, randomised parallel-group study
ML van der Kop, S Muhula, PI Nagide, L Thabane, L Gelmon, PO Awiti, ...
The Lancet Public Health 3 (3), e143-e152, 2018
672018
The effect of weekly short message service communication on patient retention in care in the first year after HIV diagnosis: study protocol for a randomised controlled trial …
ML van der Kop, DI Ojakaa, A Patel, L Thabane, K Kinagwi, AM Ekström, ...
BMJ open 3 (6), e003155, 2013
602013
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
P Ghione, ML Palomba, AR Patel, S Bobillo, K Deighton, CA Jacobson, ...
Blood, The Journal of the American Society of Hematology 140 (8), 851-860, 2022
462022
The impact of pharmacy-based immunization services on the likelihood of immunization in the United States
AR Patel, AB Breck, MR Law
Journal of the American Pharmacists Association 58 (5), 505-514. e2, 2018
442018
Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in Kenya
AR Patel, J Kessler, RS Braithwaite, KA Nucifora, H Thirumurthy, Q Zhou, ...
Medicine 96 (7), e6078, 2017
442017
The effect of weekly text-message communication on treatment completion among patients with latent tuberculosis infection: study protocol for a randomised controlled trial …
ML van der Kop, J Memetovic, A Patel, F Marra, M Sadatsafavi, J Hajek, ...
BMJ open 4 (4), e004362, 2014
332014
The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya
AR Patel, RT Lester, CA Marra, ML van der Kop, P Ritvo, L Engel, ...
Health and Quality of Life Outcomes 15, 1-9, 2017
322017
Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study
AR Patel, JR Campbell, M Sadatsafavi, F Marra, JC Johnston, K Smillie, ...
BMJ open 7 (9), e015108, 2017
292017
The cost-effectiveness of axicabtagene ciloleucel as second-line therapy in patients with large B-cell lymphoma in the United States: an economic evaluation of the ZUMA-7 trial
MA Perales, J Kuruvilla, JT Snider, S Vadgama, R Blissett, F El-Moustaid, ...
Transplantation and cellular therapy 28 (11), 750. e1-750. e6, 2022
20*2022
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
P Ghione, ML Palomba, H Ghesquieres, S Bobillo, AR Patel, M Nahas, ...
Haematologica 108 (3), 822, 2023
172023
Gender differences in health-related quality of life at the time of a positive HIV test–a cross-sectional study in a resource-poor, high prevalence setting in Nairobi, Kenya
ML van der Kop, S Muhula, A Patel, L Thabane, P Awiti, L Kyomuhangi, ...
AIDS care 30 (4), 493-499, 2018
142018
Real-world impact of time from leukapheresis to infusion (vein-to-vein time) in patients with relapsed or refractory (r/r) large B-cell lymphoma (LBCL) treated with …
FL Locke, ZH Hu, T Siddiqi, CA Jacobson, S Nikiforow, S Ahmed, ...
Blood 140 (Supplement 1), 7512-7515, 2022
132022
Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis
S Kanters, G Ball, B Kahl, A Wiesinger, EH Limbrick-Oldfield, A Sudhindra, ...
BMC cancer 23 (1), 74, 2023
122023
Characteristics and treatment patterns of newly diagnosed open-angle glaucoma patients in the United States: an administrative database analysis
GF Schwartz, A Patel, R Naik, O Lunacsek, A Ogbonnaya, J Campbell
Ophthalmology Glaucoma 4 (2), 117-125, 2021
122021
Targeting an alcohol intervention cost‐effectively to persons living with HIV/AIDS in East Africa
J Kessler, K Ruggles, A Patel, K Nucifora, L Li, MS Roberts, K Bryant, ...
Alcoholism: Clinical and Experimental Research 39 (11), 2179-2188, 2015
112015
Cost-effectiveness of axicabtagene ciloleucel versus lisocabtagene maraleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of …
OO Oluwole, R Liu, I Diakite, C Feng, A Patel, I Nourhussein, JT Snider, ...
Journal of Medical Economics 25 (1), 541-551, 2022
102022
A comparison of clinical outcomes from ZUMA-5 (axicabtagene ciloleucel) and the international SCHOLAR-5 external control cohort in relapsed/refractory follicular lymphoma (r/r FL)
P Ghione, AR Patel, S Bobillo, K Deighton, J Gribben
Blood 138 (suppl 1), 3543, 2021
92021
Economic and clinical burden associated with intensification of glaucoma topical therapy: a US claims-based analysis
AR Patel, GF Schwartz, JH Campbell, CC Chen, CB McGuiness, ...
Journal of glaucoma 30 (3), 242-250, 2021
92021
系统目前无法执行此操作,请稍后再试。
文章 1–20